Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin: A multidisciplinary approach

A. Carter, Alex Ortega Loayza, J. Barrett, J. R. Nunley

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Calciphylaxis is characterized by abnormal calcification of vessels and skin; however, its aetiology and pathogenesis remain unclear. Entities frequently associated with calciphylaxis are end-stage renal disease, diabetes mellitus, hypercalcaemia, hyperphosphataemia, elevated calcium-phosphate product, hyperparathyroidism and possible hypercoagulable states. Skin lesions may remain quiescent or may develop suddenly and progress rapidly. They are more common on the legs. Treatment of calciphylaxis is very challenging and requires interdisciplinary management. We present a case that highlights the difficulty of treating calciphylaxis. A multidisciplinary approach was vital for the proper treatment of our patient. This case also demonstrates the importance of searching for underlying hypercoagulable states, especially in recalcitrant cases. In cases of calciphylaxis with vessel occlusion from microthrombi, heparin therapy would be a logical next step. The effect of anticoagulation may be rapid and impressive.

Original languageEnglish (US)
Pages (from-to)275-278
Number of pages4
JournalClinical and Experimental Dermatology
Volume41
Issue number3
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

Fingerprint

Calciphylaxis
Thrombophilia
Heparin
Skin
Hyperparathyroidism
Hypercalcemia
Chronic Kidney Failure
Leg
Diabetes Mellitus
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin : A multidisciplinary approach. / Carter, A.; Ortega Loayza, Alex; Barrett, J.; Nunley, J. R.

In: Clinical and Experimental Dermatology, Vol. 41, No. 3, 01.04.2016, p. 275-278.

Research output: Contribution to journalArticle

@article{2d7a272b6f4d49f9996a4fc53af12dc4,
title = "Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin: A multidisciplinary approach",
abstract = "Calciphylaxis is characterized by abnormal calcification of vessels and skin; however, its aetiology and pathogenesis remain unclear. Entities frequently associated with calciphylaxis are end-stage renal disease, diabetes mellitus, hypercalcaemia, hyperphosphataemia, elevated calcium-phosphate product, hyperparathyroidism and possible hypercoagulable states. Skin lesions may remain quiescent or may develop suddenly and progress rapidly. They are more common on the legs. Treatment of calciphylaxis is very challenging and requires interdisciplinary management. We present a case that highlights the difficulty of treating calciphylaxis. A multidisciplinary approach was vital for the proper treatment of our patient. This case also demonstrates the importance of searching for underlying hypercoagulable states, especially in recalcitrant cases. In cases of calciphylaxis with vessel occlusion from microthrombi, heparin therapy would be a logical next step. The effect of anticoagulation may be rapid and impressive.",
author = "A. Carter and {Ortega Loayza}, Alex and J. Barrett and Nunley, {J. R.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1111/ced.12729",
language = "English (US)",
volume = "41",
pages = "275--278",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin

T2 - A multidisciplinary approach

AU - Carter, A.

AU - Ortega Loayza, Alex

AU - Barrett, J.

AU - Nunley, J. R.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Calciphylaxis is characterized by abnormal calcification of vessels and skin; however, its aetiology and pathogenesis remain unclear. Entities frequently associated with calciphylaxis are end-stage renal disease, diabetes mellitus, hypercalcaemia, hyperphosphataemia, elevated calcium-phosphate product, hyperparathyroidism and possible hypercoagulable states. Skin lesions may remain quiescent or may develop suddenly and progress rapidly. They are more common on the legs. Treatment of calciphylaxis is very challenging and requires interdisciplinary management. We present a case that highlights the difficulty of treating calciphylaxis. A multidisciplinary approach was vital for the proper treatment of our patient. This case also demonstrates the importance of searching for underlying hypercoagulable states, especially in recalcitrant cases. In cases of calciphylaxis with vessel occlusion from microthrombi, heparin therapy would be a logical next step. The effect of anticoagulation may be rapid and impressive.

AB - Calciphylaxis is characterized by abnormal calcification of vessels and skin; however, its aetiology and pathogenesis remain unclear. Entities frequently associated with calciphylaxis are end-stage renal disease, diabetes mellitus, hypercalcaemia, hyperphosphataemia, elevated calcium-phosphate product, hyperparathyroidism and possible hypercoagulable states. Skin lesions may remain quiescent or may develop suddenly and progress rapidly. They are more common on the legs. Treatment of calciphylaxis is very challenging and requires interdisciplinary management. We present a case that highlights the difficulty of treating calciphylaxis. A multidisciplinary approach was vital for the proper treatment of our patient. This case also demonstrates the importance of searching for underlying hypercoagulable states, especially in recalcitrant cases. In cases of calciphylaxis with vessel occlusion from microthrombi, heparin therapy would be a logical next step. The effect of anticoagulation may be rapid and impressive.

UR - http://www.scopus.com/inward/record.url?scp=84961876872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961876872&partnerID=8YFLogxK

U2 - 10.1111/ced.12729

DO - 10.1111/ced.12729

M3 - Article

C2 - 26290127

AN - SCOPUS:84961876872

VL - 41

SP - 275

EP - 278

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 3

ER -